Mothercare (MTC) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
24 Feb, 2026Executive summary
Worldwide retail sales by franchise partners fell 18% year-over-year to £230.6m, mainly due to Middle East uncertainty and the end of the UK Boots partnership.
Adjusted EBITDA dropped to £3.5m from £6.9m, with an adjusted loss before tax of £2.5m (2024: £3.5m profit).
A joint venture with Reliance in South Asia and refinancing reduced net borrowings to £3.7m (2024: £14.7m).
The business remains asset-light, focused on global franchising and brand management.
Financial highlights
Revenue: £38.9m (2024: £56.2m); profit from operations: £16.0m (2024: £6.7m).
Statutory profit after tax: £6.2m (2024: £3.3m); adjusted loss: £2.5m (2024: £3.5m profit).
Net borrowings at year-end: £3.7m; cash: £4.3m.
Net liabilities improved to £9.4m from £30.1m, driven by the JV and debt reduction.
Pension deficit reduced to £21.1m (2024: £24.2m).
Outlook and guidance
Focus on restoring UK presence, expanding into new markets, and leveraging the South Asia JV and Turkey license.
Board expects the business model can support higher volumes, with most incremental income dropping to the bottom line.
Ongoing discussions with lenders and pension trustees to defer payments and renegotiate terms.
Latest events from Mothercare
- Adjusted EBITDA grew to £6.9m as debt refinancing and a South Asia JV improved financial stability.MTC
H2 202424 Feb 2026 - Retail sales fell 25% and EBITDA dropped, but debt reduction and new partnerships offer growth potential.MTC
H1 202629 Dec 2025 - Sales fell 18% amid Middle East headwinds, but net borrowings dropped and growth plans continue.MTC
Trading Update6 Jun 2025 - Profitability improved despite a 15% sales drop, with refinancing and cost control in focus.MTC
H1 20245 Jun 2025 - Retail sales declined, but profitability improved and refinancing efforts are in progress.MTC
Trading Update5 Jun 2025 - New South Asian JV and refinancing de-leverage Mothercare amid ongoing Middle East challenges.MTC
H1 20255 Jun 2025